Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 18251-18300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06559241
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated with Mechanical Thrombectomy(RECAST-MT)
PHASE3Recruiting
2,105 participants
Started: Sep 23, 2024 · Completed: Feb 28, 2027
2 conditions1 sponsor33 locations
NCT06004232
Prenatal Yoga to Prevent Postpartum Depression
NARecruiting
62 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2026
1 condition3 sponsors1 location
NCT06959342
Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treatment for Substance Use Disorder
NARecruiting
162 participants
Started: Sep 23, 2024 · Completed: Sep 30, 2027
2 conditions2 sponsors2 locations
NCT06550596
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
NARecruiting
100 participants
Started: Sep 23, 2024 · Completed: Oct 31, 2025
4 conditions2 sponsors1 location
NCT06570772
Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio
PHASE3Recruiting
748 participants
Started: Sep 23, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor100 locations
NCT06597331
Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital
N/ARecruiting
200 participants
Started: Sep 23, 2024 · Completed: Sep 1, 2027
3 conditions1 sponsor1 location
NCT06574360
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
PHASE2Recruiting
90 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2029
1 condition1 sponsor1 location
NCT06570902
Prospective WCD Post CABG Registry (CABG Registry)
N/ARecruiting
910 participants
Started: Sep 23, 2024 · Completed: May 31, 2030
4 conditions1 sponsor4 locations
NCT06983509
Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy
N/ARecruiting
220 participants
Started: Sep 23, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor10 locations
NCT06571513
Written Exposure Therapy to Improve Recovery Among Sexual Assault Survivors
NARecruiting
80 participants
Started: Sep 23, 2024 · Completed: Jul 31, 2026
1 condition3 sponsors1 location
NCT06524843
Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma
N/ARecruiting
250 participants
Started: Sep 23, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06655805
Registry for Automated Mechanical VEntilation in Adults
N/ARecruiting
1,000 participants
Started: Sep 23, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor3 locations
NCT07112989
Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors
N/ARecruiting
125 participants
Started: Sep 23, 2024 · Completed: Sep 23, 2031
3 conditions1 sponsor1 location
NCT06400563
MRg-NIRS Imaging System Breast Cancer Trial
NARecruiting
20 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06001749
Psilocybin in Cancer Pain Study
PHASE2Recruiting
15 participants
Started: Sep 23, 2024 · Completed: Dec 31, 2026
5 conditions3 sponsors1 location
NCT06575660
Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease
NARecruiting
28 participants
Started: Sep 23, 2024 · Completed: Nov 30, 2025
5 conditions2 sponsors1 location
NCT06562153
fMRI Accelerated TMS Depression
N/ARecruiting
20 participants
Started: Sep 23, 2024 · Completed: Aug 5, 2026
1 condition2 sponsors1 location
NCT06441747
Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)
PHASE2Recruiting
40 participants
Started: Sep 23, 2024 · Completed: Aug 31, 2028
1 condition3 sponsors8 locations
NCT06384560
Neoadjuvant Triple Treatment for Borderline Resectable Pancreatic Cancer (PREOPANC-5)
PHASE1/PHASE2Recruiting
66 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2028
1 condition4 sponsors4 locations
NCT06536647
Contactless Assessment of Patient Vital Signs for Triage Using Remote Photoplethysmography in the Emergency Department
N/ARecruiting
1,200 participants
Started: Sep 23, 2024 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT06648057
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
N/ARecruiting
100 participants
Started: Sep 23, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06666660
Daily Intake of Multivitamin & Mineral Supplementation Effects on Biological Age of Relatively Healthy Middle-aged Individuals
NARecruiting
400 participants
Started: Sep 23, 2024 · Completed: Jun 30, 2025
1 condition2 sponsors2 locations
NCT06246357
Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism
PHASE2Recruiting
80 participants
Started: Sep 23, 2024 · Completed: Apr 1, 2028
3 conditions1 sponsor1 location
NCT06621849
Effect of Unilateral Erector Spinae Plane Block Versus Intrathecal Morphine on Early Mobilization After Hip Replacement
EARLY_PHASE1Recruiting
70 participants
Started: Sep 23, 2024 · Completed: Jul 23, 2025
1 condition1 sponsor1 location
NCT06497556
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE3Recruiting
320 participants
Started: Sep 23, 2024 · Completed: Nov 30, 2029
2 conditions2 sponsors253 locations
NCT06240481
Clinical Research Study to Assess the Efficacy of Two Brushing Regimens
PHASE3Recruiting
90 participants
Started: Sep 23, 2024 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06681922
A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
PHASE1/PHASE2Recruiting
10 participants
Started: Sep 23, 2024 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT06555796
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
PHASE1Recruiting
50 participants
Started: Sep 23, 2024 · Completed: Jun 21, 2029
4 conditions1 sponsor10 locations
NCT06465966
UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning
NARecruiting
30 participants
Started: Sep 23, 2024 · Completed: Oct 1, 2027
1 condition1 sponsor1 location
NCT06375278
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
NARecruiting
54 participants
Started: Sep 23, 2024 · Completed: Jul 31, 2026
3 conditions3 sponsors1 location
NCT06413680
A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies
PHASE1/PHASE2Recruiting
150 participants
Started: Sep 23, 2024 · Completed: Feb 3, 2030
3 conditions1 sponsor11 locations
NCT06311266
Robotic Endoscopic Neurosurgical Interventions
NARecruiting
19 participants
Started: Sep 23, 2024 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06100614
Presepsin to Safely Reduce Antibiotics in Preterm Infants
NARecruiting
900 participants
Started: Sep 23, 2024 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT06569212
Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS)
PHASE4Recruiting
20 participants
Started: Sep 23, 2024 · Completed: Sep 30, 2029
1 condition2 sponsors1 location
NCT06649630
A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy Men
PHASE1Recruiting
108 participants
Started: Sep 23, 2024 · Completed: May 4, 2026
1 condition1 sponsor2 locations
NCT06529731
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
PHASE2Recruiting
45 participants
Started: Sep 23, 2024 · Completed: Oct 31, 2027
2 conditions4 sponsors3 locations
NCT06193343
Steps Towards Osteoarthritis Prevention
NARecruiting
56 participants
Started: Sep 23, 2024 · Completed: Jan 30, 2028
1 condition2 sponsors1 location
NCT05933395
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
PHASE2Recruiting
135 participants
Started: Sep 23, 2024 · Completed: Oct 31, 2031
1 condition1 sponsor1 location
NCT06415032
Quilting Sutures After Mastectomy
NARecruiting
296 participants
Started: Sep 23, 2024 · Completed: Oct 31, 2027
1 condition2 sponsors1 location
NCT06580080
Evaluation of Are You Ready?
NARecruiting
1,850 participants
Started: Sep 23, 2024 · Completed: Sep 14, 2028
1 condition5 sponsors1 location
NCT06348719
Medico-economic Evaluation of Robot-assisted Laparoscopy Compared With Conventional Laparoscopy in Hysterectomy for Endometrial Cancer.
NARecruiting
1,680 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2028
1 condition1 sponsor15 locations
NCT06472206
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
NARecruiting
420 participants
Started: Sep 23, 2024 · Completed: Dec 22, 2027
1 condition8 sponsors5 locations
NCT06641687
Be Sweet to Babies During Nasolaryngoscopy
NARecruiting
60 participants
Started: Sep 23, 2024 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT06625749
Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery
NARecruiting
10 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT06284486
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
PHASE1/PHASE2Recruiting
8 participants
Started: Sep 23, 2024 · Completed: Dec 30, 2028
1 condition3 sponsors4 locations
NCT06601907
Researching the Effectiveness of a Alivis, a Digital Health Application for Borderline Personality Disorder
NARecruiting
470 participants
Started: Sep 23, 2024 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06486974
Efficacy of Manual Toothbrushes in Removing Tooth Stains
PHASE3Recruiting
80 participants
Started: Sep 23, 2024 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT06492707
DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial
PHASE1Recruiting
20 participants
Started: Sep 23, 2024 · Completed: Oct 1, 2027
4 conditions2 sponsors1 location
NCT06172933
A Text- and Audio-based Intervention to Promote Physical Activity in Midlife
NARecruiting
30 participants
Started: Sep 23, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT07036536
Non-Euploid Embryo Transfer (NEET) Registry
N/ARecruiting
1,000 participants
Started: Sep 23, 2024 · Completed: Dec 31, 2030
3 conditions3 sponsors1 location